Valuation: Devyser Diagnostics AB

Market Cap 90Cr 9.06Cr 8.04Cr 7.52Cr 6.82Cr 13Cr 873.04Cr 13Cr 35Cr 445.37Cr 34Cr 33Cr 1.43TCr P/E 2026 *
88.3x
P/E 2027 * 27.7x
Enterprise Value 86Cr 8.59Cr 7.62Cr 7.13Cr 6.46Cr 12Cr 827.59Cr 12Cr 33Cr 422.19Cr 32Cr 32Cr 1.36TCr EV / Sales 2026 *
3.48x
EV / Sales 2027 * 2.91x
Free-Float
70.78%
Yield 2026 *
-
Yield 2027 * -
1 day+1.16%
1 week+7.05%
Current month+8.14%
1 month-10.56%
3 months-35.86%
6 months-32.32%
Current year-53.18%
1 week 4.42
Extreme 4.415
4.82
1 month 4.38
Extreme 4.385
5.36
Current year 4.38
Extreme 4.385
10.56
1 year 4.38
Extreme 4.385
12.72
3 years 4.38
Extreme 4.385
14.2
5 years 4.38
Extreme 4.385
14.2
10 years 4.38
Extreme 4.385
14.2
Manager TitleAgeSince
Chief Executive Officer 59 04/08/2025
Director of Finance/CFO 43 01/01/2021
Chief Tech/Sci/R&D Officer 48 01/02/2024
Director TitleAgeSince
Chairman 57 27/05/2021
Director/Board Member 49 01/01/2021
Director/Board Member 72 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
+1.16%+7.05% - - 9.08Cr
+4.16%+3.42%+49.37%+94.17% 7.43TCr
+2.76%-1.16%+23.05%+83.03% 5.7TCr
+0.24%-1.37%+4.08%+37.22% 4.83TCr
-3.76%-0.93%+327.90%+691.25% 4.45TCr
-2.30%-4.06%+25.82%+31.42% 4.38TCr
+0.31%-1.15%+5.50%+112.56% 4.11TCr
-0.11%+2.30%+9.19%+58.68% 3.11TCr
+4.51%+8.43%+37.27%+34.97% 2.9TCr
-1.96%-3.38%-9.25%-12.85% 2.45TCr
Average +0.49%-0.20%+52.55%+125.61% 4.37TCr
Weighted average by Cap. +0.75%-0.50%+56.58%+134.21%

Financials

2026 *2027 *
Net sales 25Cr 2.47Cr 2.19Cr 2.05Cr 1.86Cr 3.51Cr 237.63Cr 3.53Cr 9.57Cr 121.22Cr 9.25Cr 9.05Cr 389.7Cr 30Cr 2.98Cr 2.65Cr 2.48Cr 2.25Cr 4.24Cr 287.51Cr 4.27Cr 12Cr 146.67Cr 11Cr 11Cr 471.5Cr
Net income 1.01Cr 10.09L 9L 8L 8L 14.35L 9.73Cr 14.45L 39.15L 4.96Cr 37.87L 37.06L 16Cr 3.2Cr 32.05L 28.45L 26.62L 24.13L 45.57L 31Cr 45.9L 1.24Cr 16Cr 1.2Cr 1.18Cr 51Cr
Net Debt -4.7Cr -47.15L -41.85L -39.17L -35.5L -67.05L -45Cr -67.53L -1.83Cr -23Cr -1.77Cr -1.73Cr -75Cr -3.9Cr -39.09L -34.7L -32.47L -29.43L -55.58L -38Cr -55.99L -1.52Cr -19Cr -1.47Cr -1.44Cr -62Cr
Projected Income Statement - Annual - Devyser Diagnostics AB
Logo Devyser Diagnostics AB
Devyser Diagnostics AB is a Sweden-based company engaged in development, manufacture ad sale of kits for genetic testing in routing diagnostic to laboratories. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The company has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The Company provides its products in more than 45 countries.
Employees
110
Date Price Change
07/26/07 €4.785 +1.16%
05/26/05 €4.730 -1.15%
02/26/02 €4.785 +6.22%
01/26/01 €4.505 +1.81%
30/26/30 €4.425 -0.23%
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Devyser Diagnostics AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
35.84DKK
Average target price
65.94DKK
Spread / Average Target
+83.98%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Devyser Diagnostics AB